Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?
Open Access
- 16 November 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 20 (1) , 6-10
- https://doi.org/10.1093/ndt/gfh570
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cellsHepatology Research, 2003
- Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary reportKidney International, 2003
- Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal developmentDevelopment, 2003
- Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy11Professor Robert Chevalier served as a guest editor for this paper.Kidney International, 2003
- Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?Matrix Biology, 2002
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature Cell Biology, 2002
- Role of connective tissue growth factor in the pathogenesis of diabetic nephropathyBiochemical Journal, 2001
- Connective tissue growth factor: just another factor in renal fibrosis?Nephrology Dialysis Transplantation, 2000
- Expression of connective tissue growth factor in human renal fibrosisKidney International, 1998
- Therapeutic approaches to organ fibrosisThe International Journal of Biochemistry & Cell Biology, 1997